![Two Perspectives: Patient and Hematopathologist Discussion on Importance of CML Monitoring - The Pathologist Two Perspectives: Patient and Hematopathologist Discussion on Importance of CML Monitoring - The Pathologist](https://thepathologist.videomarketingplatform.co/64968576/74640577/865a810b05db8d8b1d16679ba767d260/large/download-12-thumbnail.jpg)
Two Perspectives: Patient and Hematopathologist Discussion on Importance of CML Monitoring - The Pathologist
Blood and Hematology - Molecular monitoring in CML: how deep? How often? How should it influence therapy? With the advent of tyrosine kinase inhibitors (TKIs), the goals of therapy in chronic myeloid
![PDF] Laboratory tools for diagnosis and monitoring response in patients with chronic myeloid leukemia. | Semantic Scholar PDF] Laboratory tools for diagnosis and monitoring response in patients with chronic myeloid leukemia. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6a1da8533fa234a77234b2a6f44caad836fe4334/2-Table1-1.png)
PDF] Laboratory tools for diagnosis and monitoring response in patients with chronic myeloid leukemia. | Semantic Scholar
![JCM | Free Full-Text | Molecular Testing in CML between Old and New Methods: Are We at a Turning Point? JCM | Free Full-Text | Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?](https://www.mdpi.com/jcm/jcm-09-03865/article_deploy/html/images/jcm-09-03865-g004.png)
JCM | Free Full-Text | Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?
Analytical Validation of a Highly Sensitive, Multiplexed Chronic Myeloid Leukemia Monitoring System Targeting BCR-ABL1 RNA
A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib | PLOS ONE
![Frontiers | Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches Frontiers | Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches](https://www.frontiersin.org/files/Articles/458509/fonc-09-00833-HTML/image_m/fonc-09-00833-g006.jpg)
Frontiers | Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches
![JCM | Free Full-Text | Molecular Testing in CML between Old and New Methods: Are We at a Turning Point? JCM | Free Full-Text | Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?](https://www.mdpi.com/jcm/jcm-09-03865/article_deploy/html/images/jcm-09-03865-g001.png)
JCM | Free Full-Text | Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?
![Chronic myeloid leukemia: cytogenetics and molecular biology's part in the comprehension and management of the pathology and treatment evolution | Egyptian Journal of Medical Human Genetics | Full Text Chronic myeloid leukemia: cytogenetics and molecular biology's part in the comprehension and management of the pathology and treatment evolution | Egyptian Journal of Medical Human Genetics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs43042-022-00248-2/MediaObjects/43042_2022_248_Fig1_HTML.png)